Brief: Xvivo Receives CE Certificates For Heart Preservation Technology
BRIEF-Xvivo Receives CE Certificates For Heart Preservation Technology Aug 11 (Reuters) - Xvivo Perfusion AB XVIVO.ST:
XVIVO PERFUSION AB: XVIVO RECEIVES CE CERTIFICATES FOR ITS GROUNDBREAKING HEART PRESERVATION TECHNOLOGY, TRANSFORMING ACCESS TO LIFE-SAVING TRANSPLANTS ACROSS EUROPE
XVIVO HEART TECHNOLOGY IS NOT COMMERCIALLY AVAILABLE IN US.
Source text: ID:nMFNdn3PG
Further company coverage: XVIVO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Xvivo Perfusion AB
See all newsSweden's XVIVO Q3 revenue beat expectations on thoracic sales
Brief: Xvivo Q3 EBIT SEK 28 Million
Brief: Xvivo Receives CE Certificates For Heart Preservation Technology
Brief: XVIVO Gets FDA Approval For Additional Patient Enrollment
Sweden's XVIVO Q2 sales beat estimates, helped by thoracic segment strength